The CHAPPP study: Changing care with PSMA-PET for Prostate cancer—A retrospective study of the role of PSMA imaging in altering treatment pathways.

Authors

Andrew Schmidt

Andrew Schmidt

Royal Brisbane and Women's Hospital, Brisbane, Australia

Andrew Schmidt , Jeffrey C. Goh , Manoj Bhatt , Paul Thomas , Aneta Suder

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 13)

DOI

10.1200/JCO.2017.35.6_suppl.13

Abstract #

13

Poster Bd #

A14

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.

Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.

First Author: Ahmed M. Mahmoud

First Author: Alberto Carretero-González

First Author: Markus Grabbert